Trends in Anti-Vascular Endothelial Growth Factor Original Medicare Part B Claims in the United States, 2014

登录注册会员服务联系我们

Trends in Anti-Vascular Endothelial Growth Factor Original Medicare Part B Claims in the United States, 2014–2019

Published:2024-02-05 Issue:5 Volume:31 Page:468-477
ISSN:0928-6586
Container-title:Ophthalmic Epidemiology
language:en
Short-container-title:Ophthalmic Epidemiology

Author:

Desai Sarishka¹,Sekimitsu Sayuri²,Rossin Elizabeth J.³⁴,Zebardast Nazlee³⁴

Affiliation:

1. University of Connecticut School of Medicine, Farmington, Connecticut, USA

2. Tufts University School of Medicine, Boston, Massachusetts, USA

3. Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA

4. Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA

Funder

conducted as part of authors’ regular

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09286586.2024.2310854

Reference47 articles.

1. Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options

2. Vascular endothelial growth factor in eye disease

3. Anti-VEGF drugs in the prevention of blindness;Yorston D;Community Eye Health,2014

4. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

5. A Brief History of Anti-VEGF for the Treatment of Ocular Angiogenesis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incisional choroidal surgery;Survey of Ophthalmology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP